Viralgen, a leader in AAV gene therapy manufacturing, has joined forces with two labs from the prestigious Broad Institute of MIT and Harvard University to develop an innovative treatment for prion disease. This partnership brings together expertise in gene therapy
Viralgen Vector Core Contract Manufacturing & Development (CDMO) Profile At Viralgen we specialize in the production of rAAV viral vectors, and have built an optimized facility that maximizes throughput and efficiency of our proprietary Pro10â„¢ suspension manufacturing platform, enabling industry-leading
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
